MDI Limbach Berlin
MDI Limbach Berlin is a medical laboratory in Berlin, Germany, providing comprehensive diagnostic services with a focus on quality and reliability.
MDI Limbach Berlin is a medical laboratory based in Berlin, Germany, with over 60 years of experience in providing high-quality diagnostic services. The laboratory offers a wide range of medical tests and analyses, serving both healthcare professionals and patients. Committed to excellence, MDI Limbach Berlin employs a team of experts dedicated to delivering accurate and timely results, supporting effective patient care.
Locations
Treatments
Allgemeine Gesundheitsvorsorge (General Health Check)
Comprehensive general health screening analyzing 22 biomarkers for cardiovascular, metabolic, liver, kidney, and thyroid function. Venous blood sample with fasting required (8-12 hours). Results typically within 2-3 business days via patient portal (patientenauskunft.mdi-limbach-berlin.de) using 8-digit order number. Price based on GOÄ 1.0 fee scale for statutory health insurance patients; privately insured patients billed at 1.15x multiplier. Ideal for annual health monitoring and disease prevention. Biomarkers tested: Blood Chemistry - alkaline phosphatase (bone and liver enzyme), bilirubin (liver function, bile flow), calcium (bone health, nerve function), total protein (nutrition status, liver/kidney function), urea (kidney function), potassium (electrolyte balance, heart rhythm), sodium (fluid balance, blood pressure); Blood Count - large blood count (CBC with differential) detecting anemia, infection, immune disorders including RBC, WBC, hemoglobin, hematocrit, platelets, neutrophils, lymphocytes, monocytes, eosinophils, basophils; Cardiovascular - total cholesterol, HDL cholesterol ("good"), LDL cholesterol ("bad"), triglycerides (fat metabolism); Inflammation - CRP (C-reactive protein, acute inflammation marker); Liver - gamma-GT (alcohol consumption, bile flow), GOT/ASAT (liver cell damage), GPT/ALAT (liver inflammation); Metabolism - fasting glucose (diabetes screening), HbA1c implicitly assessed, uric acid (gout risk); Kidney - creatinine (filtration), urea (protein metabolism); Thyroid - TSH (thyroid stimulating hormone for hyper/hypothyroidism). Covers all major organ systems for comprehensive preventive health assessment. Appointment booking via Doctolib, phlebotomy €4.20 additional.
€76.34
Veggie-Check (Vegetarian/Vegan Nutrition Panel)
Specialized nutritional status screening for vegetarians and vegans analyzing 11 biomarkers commonly deficient in plant-based diets. Venous blood sample with fasting recommended. Results via patient portal within 3-5 days. Essential for anyone following plant-based diet to detect and prevent nutritional deficiencies affecting energy, immunity, cardiovascular and cognitive health. Biomarkers tested: Blood Count - small blood count (CBC) including RBC, WBC, hemoglobin, hematocrit, platelets detecting anemia from B12/iron deficiency; Minerals - calcium (bone health, nerve transmission, muscle function), iron (oxygen transport, energy production), ferritin (iron stores, most sensitive indicator of iron deficiency), selenium (antioxidant, immune function, thyroid health), zinc (immune function, wound healing, taste/smell, DNA synthesis); Vitamins - holotranscobalamin (active vitamin B12, earliest marker of B12 deficiency before anemia develops, critical for vegans), vitamin D 25-OH (bone health, immune function, mood - often low in northern climates regardless of diet); Cardiovascular/Energy - coenzyme Q10 (cellular energy production, antioxidant, heart health), omega-3 fatty acids (EPA+DHA levels, brain health, inflammation reduction - typically low in vegans without algae supplementation); Protein Status - total protein (adequate amino acid intake from plant sources). Comprehensive assessment addresses highest-risk nutrients in plant-based diets. Recommended annually or when experiencing fatigue, weakness, or starting plant-based diet. GOÄ 1.0 pricing; privately insured 1.15x.
€176.81
Sport-Check 30 Jahre Plus (Athletic Cardiovascular Panel)
Cardiovascular risk assessment panel for athletes and active adults over 30 analyzing 5 lipid biomarkers critical for heart health during intensive training. Venous blood sample with 12-hour fasting required for accurate lipid measurement. Results within 2 days. Exercise increases cardiovascular demands - this panel identifies athletes at risk for atherosclerosis, heart attack, or stroke despite high fitness levels. Important because athletes can have "hidden" cardiovascular risks masked by overall fitness. Biomarkers tested: Lipid Panel - total cholesterol (overall cardiovascular risk), HDL cholesterol ("good" cholesterol, protective against heart disease, should be elevated in athletes), LDL cholesterol ("bad" cholesterol causing arterial plaque, target <100 mg/dL for athletes), lipoprotein(a) [Lp(a)] (genetic cardiovascular risk factor unaffected by diet/exercise, strong predictor of heart attack and stroke); Long-term Glucose Control - HbA1c (glycated hemoglobin reflecting 2-3 month average blood sugar, diabetes screening, metabolic health assessment - athletes should have optimal glucose control). Critical for: masters athletes resuming training, endurance athletes with family history of heart disease, strength athletes using supplements affecting lipids, anyone over 30 starting intensive exercise program. Lp(a) testing is particularly valuable as this genetic risk factor is often overlooked. Should be combined with Sport-Check Plus for comprehensive athletic health assessment. GOÄ 1.0 pricing.
€38.47
Hormonstatus Frau prämenopausal (Premenopausal Female Hormone Panel)
Comprehensive female reproductive hormone panel for women of childbearing age (typically 20-45 years) analyzing 4 key hormones regulating menstrual cycle, fertility, mood, and metabolic health. Venous blood sample with timing critical - ideally collected on Day 3-5 of menstrual cycle for FSH/LH/estradiol, Day 21 for progesterone (or 7 days before expected period). Results within 2-3 days. Essential for evaluating: irregular periods, fertility issues, PCOS, unexplained weight gain, mood disorders, low libido, PMS symptoms. Biomarkers tested: FSH (follicle-stimulating hormone) - controls egg maturation and ovarian function, elevated levels suggest diminished ovarian reserve or approaching menopause, low levels suggest pituitary dysfunction; LH (luteinizing hormone) - triggers ovulation mid-cycle, LH:FSH ratio >2:1 suggests PCOS, absent LH surge indicates anovulation; Estradiol (E2) - primary estrogen hormone, regulates menstrual cycle, bone density, cardiovascular health, brain function, libido, low levels cause irregular periods, hot flashes, vaginal dryness, high levels suggest ovarian cysts or estrogen dominance; Progesterone - produced after ovulation in luteal phase, maintains early pregnancy, balances estrogen, levels <10 ng/mL suggest anovulation or luteal phase defect, adequate levels (>10 ng/mL) confirm ovulation occurred. Panel interpretation requires understanding cycle timing and patient age. Abnormal patterns: PCOS (high LH:FSH ratio, high androgens), hypothalamic amenorrhea (low all hormones), premature ovarian insufficiency (high FSH, low estradiol). GOÄ 1.0 pricing; privately insured 1.15x. Recommend consultation with gynecologist or endocrinologist for interpretation.
€69.94
Hormonstatus Frau postmenopausal (Postmenopausal Female Hormone Panel)
Hormone panel for postmenopausal women (typically 50+ years) or those experiencing menopausal symptoms, analyzing 4 hormones to confirm menopause status and assess hormone replacement therapy (HRT) needs. Venous blood sample, timing less critical than premenopausal testing as cycles have ceased. Results within 2-3 days. Used to: confirm menopause diagnosis, evaluate symptoms (hot flashes, mood changes, low libido, vaginal dryness), monitor HRT effectiveness, assess testosterone levels affecting energy and libido in aging. Biomarkers tested: FSH (follicle-stimulating hormone) - dramatically elevated in menopause (>30-40 IU/L) as pituitary tries to stimulate declining ovarian function, levels >25 IU/L typically confirm menopausal status, useful for women with unclear menopausal status (hysterectomy, irregular periods); LH (luteinizing hormone) - also elevated in menopause (>15-20 IU/L), rises along with FSH as ovarian function ceases; Estradiol (E2) - primary estrogen, falls to very low levels in menopause (<20 pg/mL), low levels cause hot flashes, night sweats, vaginal atrophy, bone loss, cardiovascular risk, mood changes, on HRT should normalize to premenopausal range; Testosterone - androgen providing energy, libido, muscle maintenance, bone density, declines with age but more gradually than estrogen, low levels (<15 ng/dL) contribute to fatigue, low sex drive, loss of muscle mass, some HRT regimens include testosterone. Classic menopause pattern: very high FSH/LH, very low estradiol. Panel helps distinguish natural menopause from premature ovarian insufficiency (POI - before age 40) or surgical menopause. Valuable for HRT monitoring - estradiol should rise, FSH should suppress somewhat with treatment. GOÄ 1.0 pricing; privately insured 1.15x.
€69.94
Hormonstatus Mann (Male Hormone Panel)
Comprehensive male hormone panel analyzing 5 key hormones affecting energy, libido, muscle mass, mood, and metabolic health in men. Venous blood sample ideally collected in morning (7-10 AM) when testosterone peaks. Results within 2-3 days. Essential for evaluating: low energy/fatigue, decreased libido, erectile dysfunction, difficulty building muscle, increased body fat, mood disorders, infertility. Recommended for men over 40 or any age with symptoms of low testosterone (hypogonadism). Biomarkers tested: Testosterone (total) - primary male sex hormone, normal range 300-1000 ng/dL, levels <300 ng/dL diagnostic for hypogonadism, affects muscle mass, bone density, libido, mood, energy, cognition, cardiovascular health, declines ~1% annually after age 30; SHBG (sex hormone-binding globulin) - protein binding testosterone in blood, only unbound (free) testosterone is bioavailable, high SHBG reduces free testosterone availability (aging, obesity, hypothyroidism increase SHBG), calculating free testosterone requires total testosterone + SHBG; FSH (follicle-stimulating hormone) - in men stimulates sperm production in testes, elevated FSH with low testosterone suggests primary testicular failure, low FSH with low testosterone suggests pituitary/hypothalamic dysfunction, critical for fertility assessment; LH (luteinizing hormone) - stimulates testosterone production by Leydig cells, interpretation similar to FSH (high LH + low testosterone = testicular problem, low LH + low testosterone = brain problem); DHEA (dehydroepiandrosterone) - adrenal androgen precursor hormone converted to testosterone and estrogen, peaks in 20s then declines with age, provides additional androgen support beyond testosterone, affects energy, immune function, mood. Panel distinguishes primary hypogonadism (testicular failure - high LH/FSH, low testosterone) from secondary hypogonadism (pituitary/hypothalamic - low LH/FSH, low testosterone). GOÄ 1.0 pricing; privately insured 1.15x. Recommend endocrinology or urology consultation for testosterone replacement therapy (TRT) evaluation.
€82.71
Hormoncheck Wechseljahre Frauen (Menopause Transition Hormone Panel)
Specialized hormone panel for women in perimenopause (typically 40-55 years) experiencing irregular periods and menopausal symptoms, analyzing 4 biomarkers to assess ovarian reserve and menopausal transition timing. Venous blood sample, ideally Day 3-5 of cycle if still menstruating. Results within 3-4 days. Critical for women with: irregular periods after age 40, premature menopausal symptoms before 45, fertility concerns in late 30s/early 40s, unexplained hot flashes or mood changes, assessing egg reserve before fertility treatment. Biomarkers tested: FSH (follicle-stimulating hormone) - rises as ovarian function declines, levels 10-15 IU/L suggest diminished ovarian reserve, >25 IU/L approaching menopause, perimenopause shows fluctuating FSH (may be normal one month, elevated next); Estradiol (E2) - primary estrogen, erratic in perimenopause (can swing from very low causing symptoms to unexpectedly high), declining trend over time, <50 pg/mL with symptoms suggests perimenopause; DHEA (dehydroepiandrosterone) - adrenal hormone declining with age, low DHEA worsens menopausal symptoms (fatigue, low mood, decreased resilience to stress), supplementation may help symptom management; AMH (anti-Müllerian hormone) - gold standard marker of ovarian reserve, produced by follicles in ovaries, directly correlates with remaining egg supply, levels <1.0 ng/mL indicate low reserve, <0.5 ng/mL severely diminished reserve, undetectable AMH suggests menopause imminent or reached, unlike FSH/estradiol AMH does not fluctuate with cycle. Panel especially valuable for: distinguishing perimenopause from other causes of irregular periods (PCOS, thyroid), assessing fertility window in late reproductive years, timing HRT initiation, explaining symptoms when standard tests appear normal. AMH provides most stable assessment of ovarian aging. GOÄ 1.0 pricing; privately insured 1.15x.
€80.97
Erschöpfungszustand (Chronic Fatigue & Exhaustion Panel)
Comprehensive fatigue diagnostic panel analyzing 10 biomarkers across multiple systems commonly causing chronic tiredness, exhaustion, low energy, and burnout. Venous blood sample with fasting preferred. Results within 3-5 days. Essential investigation when experiencing: persistent fatigue despite adequate sleep, morning exhaustion, inability to recover from exercise, brain fog, decreased motivation, burnout symptoms, unexplained weakness. Tests most common medical causes of fatigue. Biomarkers tested: Blood Count - large blood count (CBC with differential) detecting anemia (most common cause of fatigue - iron, B12, folate deficiency), chronic inflammation, infection, bone marrow disorders; Thyroid - TSH (thyroid stimulating hormone), hypothyroidism causes profound fatigue, weight gain, cold intolerance, depression, affects 5-10% of population especially women; Vitamins - vitamin D 25-OH (deficiency causes fatigue, muscle weakness, depression, immune dysfunction, extremely common in northern Europe with 40-80% population insufficient), holotranscobalamin (active B12, earliest marker of B12 deficiency causing fatigue, neurological symptoms, anemia, vegans/elderly at high risk), folate (vitamin B9, deficiency causes anemia, fatigue, poor concentration); Minerals - ferritin (iron stores, low ferritin causes fatigue even without anemia, women/vegetarians/athletes at risk), selenium (thyroid function, antioxidant, immune health, deficiency causes fatigue and susceptibility to illness); Hormones - cortisol (morning fasting sample ideal, low cortisol suggests adrenal insufficiency or HPA axis dysfunction from chronic stress, high cortisol indicates active stress response), parathyroid hormone (PTH, calcium/vitamin D metabolism, elevated with vitamin D deficiency causing fatigue and weakness); Metabolism - HbA1c (3-month glucose average, diabetes and prediabetes cause significant fatigue from poor glucose regulation). Comprehensive panel efficiently identifies treatable causes of fatigue: hypothyroidism (levothyroxine), vitamin D deficiency (supplementation), B12/folate deficiency (supplementation/injections), iron deficiency (supplementation, investigate cause), diabetes (lifestyle/medication). Most patients with chronic fatigue have 1-3 abnormal results providing actionable treatment. GOÄ 1.0 pricing; privately insured 1.15x. Recommend follow-up with GP or endocrinologist for treatment plan.
€160.01
Drogenscreening (Drug Screening Panel)
Comprehensive urine drug screening panel detecting 7 major drug classes plus creatinine validity check. Urine sample (20-30 mL) collected on-site or at home. Results typically within 24-48 hours. Used for: workplace drug testing, pre-employment screening, substance abuse monitoring, court-ordered testing, athletic doping control, rehabilitation program compliance, medical evaluation when intoxication suspected. Initial immunoassay screening followed by confirmation if positive. Substances tested: Amphetamines (speed, Adderall, methamphetamine) - detection window 2-5 days, stimulants causing euphoria, increased energy, appetite suppression, cardiovascular risks; Barbiturates (phenobarbital, secobarbital) - detection 2-4 days for short-acting, up to 3 weeks for long-acting, sedatives/hypnotics now rarely prescribed, high overdose risk; Benzodiazepines (Valium, Xanax, Ativan) - detection 3-7 days standard, up to 4-6 weeks for chronic use, prescription anti-anxiety/sedatives, high abuse potential; Cannabinoids (THC, marijuana) - detection highly variable, 3-7 days occasional use, 30+ days heavy chronic use due to fat storage, legal status varies by jurisdiction; Cocaine (crack, powder cocaine) - detection 2-4 days, powerful stimulant with cardiovascular and stroke risks; Methadone - detection 3-5 days, opioid agonist used for heroin addiction treatment, requires separate test from standard opiates; Opiates (heroin, morphine, codeine) - detection 2-4 days, narcotic analgesics with high addiction potential, respiratory depression risk; Creatinine - kidney marker used to validate urine sample (not diluted, not substituted), normal range 20-350 mg/dL, very low creatinine suggests sample tampering. Testing complies with German workplace drug testing regulations. Positive immunoassay results should be confirmed by GC-MS for legal/employment purposes. Price includes collection kit and shipping if applicable (up to €6.90). GOÄ 1.0 pricing; privately insured 1.15x. Results confidential unless required by court/employer.
€106.36